Singapore markets open in 5 hours 35 minutes

Straits Times Index
3,292.69
+10.64(+0.32%)
S&P 500
5,082.94
+47.25(+0.94%)
Dow
38,288.96
+473.04(+1.25%)
Nasdaq
15,872.98
+215.16(+1.37%)
Bitcoin USD
58,258.63
-1,630.62(-2.72%)
CMC Crypto 200
1,225.70
-113.37(-8.47%)

Cerus Corporation (CERS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

1.7650

+0.0950

(+5.69%)

As of 03:25PM EDT. Market open.

Trade prices are not sourced from all markets

All

Business Wire
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
CONCORD, Calif., April 18, 2024--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2024 financial results will be released on Thursday, May 2, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.
Simply Wall St.
Cerus Corporation (NASDAQ:CERS) is a favorite amongst institutional investors who own 64%
Key Insights Significantly high institutional ownership implies Cerus' stock price is sensitive to their trading...
Business Wire
Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life
CONCORD, Calif., March 26, 2024--Cerus Corporation (Nasdaq: CERS) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of 12-month shelf life for INTERCEPT Platelet Processing Sets, from the date of manufacture, effective immediately. This approval extends the set shelf life by six months from the existing six-month shelf life that took effect following a set component change last year. All INTERCEPT Platelet Processing Sets in both customer and Cerus inventories